Sealed Air's (SEE) sale to CD&R could see some investor pushback as the price is likely below expectations, according to a Wolfe Research analyst. "We sense that the deal value is below most buy-side ...
US-based private equity company Clayton, Dubilier & Rice (CD&R) is considering the potential acquisition of Sealed Air, the US packaging manufacturer known for bubble wrap. CD&R has held discussions ...
Around £500m of structured equity has been raised via a newly created SPV CD&R retains majority control of MFG CD&R first invested in MFG in 2015 CD&R will sell a minority stake in Motor Fuel Group ...
If you opened a certificate of deposit (CD) account in the past two years and are approaching a July 2025 maturity date, then you likely already know that the interest rate climate has changed ...
A Delaware judge has allowed a shareholder lawsuit challenging the $7 billion take-private acquisition of Focus Financial Partners Inc. to proceed to limited discovery, preserving a key disclosure ...
Sanofi (NASDAQ:SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, its consumer healthcare business, to private equity firm CD&R. The terms of the ...
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton Dublilier & Rice, known as CD&R. The two companies shared that they have signed ...
If you opened a certificate of deposit (CD) account in late 2022 or sometime in 2023 or 2024, you likely locked in an elevated interest rate. With rates on these accounts exponentially higher than ...
Sanofi SAN-0.34%decrease; red down pointing triangle moved ahead with a plan to sell a controlling stake in its consumer-healthcare unit Opella to Clayton Dubilier & Rice, entering exclusive talks for ...
Sanofi and CD&R enter exclusive talks to sell a 50% stake in Opella, Sanofi's consumer health unit, valued at $17.4 billion. Opella serves over 500M consumers globally with top brands like Allegra and ...
Last week, Sanofi SA (NASDAQ:SNY) said it is negotiating with Clayton Dubilier & Rice (CD&R) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business. The deal could be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results